DarioHealth Corp.: 10-Q filed 2015-08-12
What DarioHealth Corp. reported in its quarterly report filed 2015-08-12 (fiscal Q2 2015): 29 published measures, 92 facts as tagged in accession 0001144204-15-048544.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-08-12
- Fiscal period
- fiscal Q2 2015
- Accession
- 0001144204-15-048544 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All DarioHealth Corp. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 2,505,000 | USD | |
| At 2014-12-31 | 3,081,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | -5,777,000 | USD | |
| At 2014-12-31 | -5,295,000 | USD | |
| At 2013-12-31 | -86,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 981,000 | USD | |
| At 2014-12-31 | 1,453,000 | USD | |
| At 2014-06-30 | 1,819,000 | USD | |
| At 2013-12-31 | 2,263,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -2,004,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -3,642,000 | USD | 181 |
| 2014-01-01 to 2014-12-31 | -12,877,000 | USD | 365 |
| 2014-04-01 to 2014-06-30 | -3,254,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -6,238,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 46,000 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 150,000 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 175,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 242,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 0 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 0 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | -39,854,000 | USD | |
| At 2014-12-31 | -36,058,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 30,243,041 | shares | 91 |
| 2015-01-01 to 2015-06-30 | 25,845,711 | shares | 181 |
| 2014-04-01 to 2014-06-30 | 22,985,523 | shares | 91 |
| 2014-01-01 to 2014-06-30 | 22,152,675 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 30,243,041 | shares | 91 |
| 2015-01-01 to 2015-06-30 | 25,845,711 | shares | 181 |
| 2014-04-01 to 2014-06-30 | 23,202,077 | shares | 91 |
| 2014-01-01 to 2014-06-30 | 22,260,952 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -0.07 | USD/shares | 91 |
| 2015-01-01 to 2015-06-30 | -0.15 | USD/shares | 181 |
| 2014-04-01 to 2014-06-30 | -0.14 | USD/shares | 91 |
| 2014-01-01 to 2014-06-30 | -0.28 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -0.07 | USD/shares | 91 |
| 2015-01-01 to 2015-06-30 | -0.15 | USD/shares | 181 |
| 2014-04-01 to 2014-06-30 | -0.15 | USD/shares | 91 |
| 2014-01-01 to 2014-06-30 | -0.29 | USD/shares | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 854,000 | USD | |
| At 2014-12-31 | 978,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -1,512,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -3,289,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -3,603,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -6,271,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 1,611,000 | USD | |
| At 2014-12-31 | 2,056,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 1,546,000 | USD | |
| At 2014-12-31 | 1,616,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 1,277,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 2,824,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 2,998,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 5,245,000 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 207,000 | USD | |
| At 2014-12-31 | 234,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -235,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -465,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -605,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -1,026,000 | USD | 181 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 410,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 707,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 605,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 1,026,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 441,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 1,324,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,333,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 2,440,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 31,476,212 | shares | |
| At 2014-12-31 | 16,233,430 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 34,074,000 | USD | |
| At 2014-12-31 | 30,761,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 328,000 | USD | |
| At 2014-12-31 | 286,000 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -2,158,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -3,796,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -3,254,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -6,238,000 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 574,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 986,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,292,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 2,146,000 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 163,000 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 358,000 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 34,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 23,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -47,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -505,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -492,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -353,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 349,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 33,000 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | -27,000 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 22,000 | USD | 181 |
Inspect the source
- Entity
- DarioHealth Corp. / CIK 0001533998
- Captured
- 2026-09-20T09:16:34.053Z
- SEC response SHA-256
8c524c61fa46c2531eea7286cfb0614b41c397fc0b2f416d3e5df141148eb6b9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001533998.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))